Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R4.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R1.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R7.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R2.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R5.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R8.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R3.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R6.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R9.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R10.htm
XML - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC.R11.htm
EX-31.1 - EXHIBIT 31.1 - ORAMED PHARMACEUTICALS INC.exhibit_31-1.htm
EX-32.1 - EXHIBIT 32.1 - ORAMED PHARMACEUTICALS INC.exhibit_32-1.htm
EX-31.2 - EXHIBIT 31.2 - ORAMED PHARMACEUTICALS INC.exhibit_31-2.htm
10-Q - 10-Q - ORAMED PHARMACEUTICALS INC.zk1211274.htm


Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Oramed Pharmaceuticals Inc. (the “Company”) on Form 10-Q for the period ended February 29, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yifat Zommer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
Dated: April 4, 2012
By:
/s/ YIFAT ZOMMER
 
   
Name:  Yifat Zommer,
Title:    Chief Financial Officer